Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Toxic Sugar Buildup Kills Tuberculosis Bacteria

By LabMedica International staff writers
Posted on 29 Mar 2010
Interrupting the biochemical pathway leading to alpha glucan synthesis in Mycobacterium tuberculosis causes the buildup of a toxic precursor that quickly kills the microorganism.

Investigators at the Albert Einstein College of Medicine (New York, NY, USA) traced a heretofore unrecognized molecular pathway from trehalose to alpha-glucan in M. More...
tuberculosis that comprised four distinct steps mediated in turn by the enzymes TreS, Pep2, GlgE (which was identified as a maltosyltransferase that used maltose 1-phosphate), and GlgB. Alpha glucans are essential for maintaining the structure of the bacterial cell wall, and for generating new microbes through cell division.

The investigators focused their attention on the enzyme GlgE, since there are no enzymes similar to it in humans or in the bacteria of the human gut. As described in their paper published in the March 21, 2010, online issue of the journal Nature Chemical Biology, they used traditional and chemical reverse genetics to show that GlgE inactivation caused rapid death of M. tuberculosis both in vitro and in mice through a self-poisoning accumulation of the precursor maltose 1-phosphate, which damaged bacterial DNA.

"We were amazed when we knocked out GlgE that we saw this DNA damage response,” said senior author Dr. William R. Jacobs, Jr., professor of microbiology, immunology, and genetics at Albert Einstein College of Medicine. "That is usually a very effective way to kill bacteria, when you start damaging the DNA. This approach is totally different from the way any other anti-TB drug works. In the past few years, extremely drug resistant strains of TB have arisen that cannot be eliminated by any drugs, so new strategies for attacking TB are urgently needed.”

Related Links:
Albert Einstein College of Medicine




Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.